Cart
sales@molnova.com
Periplocymarin
CAS No. 32476-67-8
Periplocymarin( —— )
Catalog No. M24258 CAS No. 32476-67-8
Periplocymarin, a cardiac glycoside, has potential anti-cancer activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 149 | In Stock |
|
| 5MG | 242 | In Stock |
|
| 10MG | 419 | In Stock |
|
| 25MG | 689 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePeriplocymarin
-
NoteResearch use only, not for human use.
-
Brief DescriptionPeriplocymarin, a cardiac glycoside, has potential anti-cancer activity.
-
DescriptionPeriplocymarin, a cardiac glycoside, has potential anti-cancer activity.
-
In VitroPeriplocymarin inhibits proliferation of PC3, U937, HCT-8, Bel-7402, BGC823, A549, and A2780 cell lines in vitro with IC50 values of 0.02-0.29 μM.
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetCalcium Channel
-
RecptorCalcium Channel
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number32476-67-8
-
Formula Weight534.69
-
Molecular FormulaC30H46O8
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESO[C@@]12[C@@]3([H])[C@@](CC[C@@]1([C@@H](C4=CC(OC4)=O)CC2)C)([H])[C@@]5([C@@](O)(C[C@@H](O[C@@]6([H])C[C@@H]([C@H](O)[C@@H](C)O6)OC)CC5)CC3)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Yun W , Qian L , Cheng Y , et al. Periplocymarin Plays an Efficacious Cardiotonic Role via Promoting Calcium Influx[J]. Frontiers in Pharmacology, 2020, 11:1292.
molnova catalog
related products
-
Cronidipine
Cronidipine (LF 20254), a calcium channel antagonist, is used potentially for the treatment of hypertension and myocardia ischemia.
-
Z-944
Z-944 is a potent, highly selective and oral T-type calcium channel blocker with IC50 of 50-160 nM for human Cav3.1, Cav3.2, and Cav3.3 channels.
-
MMK 1
Potent and selective human formyl peptide receptor FPR2 agonist (EC50 values are 1, 2 and > 10 000 nM at mFRP2, hFPR2 and hFPR1 respectively). Induces migration of human monocytes and neutrophils via a chemotactic mechanism and enhances production of proinflammatory cytokines IL-1β and IL-6. Also activates the neutrophil superoxide-generating NADPH-oxidase.
